Donepezil helps patients with severe Alzheimer's disease

BMJ 2007; 335 doi: (Published 02 August 2007) Cite this as: BMJ 2007;335:226
  1. Janice Hopkins Tanne
  1. New York

    Patients with severe Alzheimer's disease who are living at home with family care givers and are treated with donepezil stabilise or decline more slowly than patients given placebo, according to a multinational, randomised, placebo controlled trial published in Neurology (2007;69:459-69).

    Donepezil was approved by the US Food and Drug Administration last year for the treatment of severe Alzheimer's disease as well as mild to moderate forms. The Canadian authorities approved its use for severe forms of the disease in June 2007.

    Sandra Black, of the University of Toronto and lead author of the paper, said that …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription